Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Jazz Pharmaceuticals PLC    JAZZ   IE00B4Q5ZN47

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products.

The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Number of employees : 810 persons.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Specialty Pharmaceutical Products585.98100%872.42100% +32.83%
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States538.2291.8%792.5290.8% +32.09%
Europe38.596.6%61.847.1% +37.6%
All Other9.171.6%18.062.1% +49.23%
Ireland-----
Managers
NameAgeSinceTitle
Bruce C. Cozadd, MBA502012Chairman & Chief Executive Officer
Russell J. Cox512012Chief Operating Officer & Executive Vice President
Matthew P. Young, MBA442013Chief Financial Officer & Senior Vice President
Mark G. Eller, PhD-2012Senior VP-Research & Clinical Development
Jeffrey K. Tobias, MD582012Chief Medical Officer, EVP-Research & Development
Paul L. Berns472010Independent Director
Bryan C. Cressey, MBA642012Independent Director
Patrick G. Enright, MBA522012Independent Director
Seamus C. Mulligan522012Director
Ken W. O'Keefe, MBA472012Independent Director
Shareholders
NameShares%
Putnam Investment Management LLC 7,647,73912.7%
Fidelity Management & Research Co. 5,695,7839.46%
Janus Capital Management LLC 3,114,6205.17%
The Vanguard Group, Inc. 3,098,9265.15%
BlackRock Fund Advisors 2,612,5364.34%
Lone Pine Capital LLC 2,087,1273.47%
Westfield Capital Management Co. LP 1,894,7213.15%
Wells Capital Management, Inc. 1,775,1272.95%
BT Investment Management Ltd. (Investment Management) 1,535,8592.55%
Seamus C. Mulligan 1,307,2052.17%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Surperformance© rating
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
GILEAD SCIENCES, ..
AMGEN, INC.
ABBVIE INC
ASTRAZENECA PLC
CELGENE CORPORATI..
BIOGEN IDEC INC
ALEXION PHARMACEU..
VERTEX PHARMACEUT..
UCB
GRIFOLS SA
JAZZ PHARMACEUTIC..
CUBIST PHARMACEUT..
CHONGQING ZHIFEI ..
-
BEIJING TIANTAN B..
-
THERAVANCE INC
WALVAX BIOTECHNOL..
-
GREEN CROSS CORP
AUXILIUM PHARMACE..
MEDY TOX INC
-
CELLDEX THERAPEUT..
Sector Pharmaceuticals
Company contact information
Jazz Pharmaceuticals Plc
Connaught House
One Burlington Road
4th floor
Dublin 4

Phone : +353.1.634.7800
Fax : +353.1.634.7850
Web : www.jazzpharma.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF